Yuri Kolesnikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuri Kolesnikov has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Gavril W. Pasternak
14 shared publicationsGavril Pasternak
Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA
5 shared publications- Gavril W. Pasternak
Cotzias Laboratory of Neuro‐Oncology, Memorial Sloan‐Kettering Cancer Center, New York, New York 10021
3 shared publications Roger Wilson
3 shared publicationsSubash Jain
3 shared publications- Abderrahman El Maarouf
Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
2 shared publications
Latest Publications
- 5 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 21 (1)
Peripheral nociceptive mechanisms — targets for local painkillers
The review is devoted to peripheral mechanisms of chronic pain and analgesia. Peripheral afferent neurons express various excitatory and inhibitory pain receptors, ion channels and proteins, such as sodium and calcium channels, alpha-adrenergic receptors, NMDA receptors, vanilloid and opioid receptors, and GABAergic receptors. These data allow the development of locally acting analgesics specifically targeting peripheral mechanisms. To date, evidence from multiple studies confirms that 5% lidocaine patches and 8% capsaicin patches are effective for patients with peripheral neuropathic pain. In turn, clinical studies confirm the effectiveness of topical application of amitriptyline, ketamine doxepin, baclofen, clonidine, morphine in the treatment of chronic pain with minimal side effects. The use of these mechanisms in creation of pain medications opens up promising prospects in the treatment of not only acute, but also chronic pain. No central side effects or their significant reduction increases the therapeutic index of peripherally acting drugs. This makes them extremely attractive for peripheral pain. Large-scale studies are needed to accelerate the introduction of these drugs into routine clinical practice.
- 5 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 21 (1)
Peripheral nociceptive mechanisms — targets for local painkillers
The review is devoted to peripheral mechanisms of chronic pain and analgesia. Peripheral afferent neurons express various excitatory and inhibitory pain receptors, ion channels and proteins, such as sodium and calcium channels, alpha-adrenergic receptors, NMDA receptors, vanilloid and opioid receptors, and GABAergic receptors. These data allow the development of locally acting analgesics specifically targeting peripheral mechanisms. To date, evidence from multiple studies confirms that 5% lidocaine patches and 8% capsaicin patches are effective for patients with peripheral neuropathic pain. In turn, clinical studies confirm the effectiveness of topical application of amitriptyline, ketamine doxepin, baclofen, clonidine, morphine in the treatment of chronic pain with minimal side effects. The use of these mechanisms in creation of pain medications opens up promising prospects in the treatment of not only acute, but also chronic pain. No central side effects or their significant reduction increases the therapeutic index of peripherally acting drugs. This makes them extremely attractive for peripheral pain. Large-scale studies are needed to accelerate the introduction of these drugs into routine clinical practice.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 19 (3)
Chronic postoperative pain syndrome: where we are in understanding the genetic risk factors, mechanisms and pharmacotherapy?
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 19 (3)
Chronic postoperative pain syndrome: where we are in understanding the genetic risk factors, mechanisms and pharmacotherapy?
- Open Access
- 1 November 2019
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 16 (5) , 5-11
Association of genetic polymorphism of guanosintriphosphate of cyclohydrolases and catechol-O-methyltransferase with the frequency of the appearance of chronic pain after surgery
Ассоциация генетического полиморфизма гуанозинтрифосфат циклогидролазы и катехол-O-метилтрансферазы с частотой появления хронической боли после операций
- 1 November 2019
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 16 (5) , 5-11
Open AccessAssociation of genetic polymorphism of guanosintriphosphate of cyclohydrolases and catechol-O-methyltransferase with the frequency of the appearance of chronic pain after surgery
Ассоциация генетического полиморфизма гуанозинтрифосфат циклогидролазы и катехол-O-метилтрансферазы с частотой появления хронической боли после операций
- Open Access
- 1 January 2019
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 16 (3) , 41-47
PROSPECTS OF USING A COMBINATION OF LOCALLY INJECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND OPIOIDS IN PERIPHERAL PAIN MANAGEMENT
ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ КОМБИНАЦИИ ЛОКАЛЬНО ВВОДИМЫХ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ СРЕДСТВ И ОПИОИДОВ В ЛЕЧЕНИИ БОЛИ ПЕРИФЕРИЧЕСКОГО ГЕНЕЗА
- 1 January 2019
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 16 (3) , 41-47
Open AccessPROSPECTS OF USING A COMBINATION OF LOCALLY INJECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND OPIOIDS IN PERIPHERAL PAIN MANAGEMENT
ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ КОМБИНАЦИИ ЛОКАЛЬНО ВВОДИМЫХ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ СРЕДСТВ И ОПИОИДОВ В ЛЕЧЕНИИ БОЛИ ПЕРИФЕРИЧЕСКОГО ГЕНЕЗА
- 1 February 2014
- Published by Elsevier in Neuropharmacology
- Vol. 77, 422-427
Morphine modifies the cingulate–operculum network underlying painful rectal evoked potentials
- 1 February 2014
- Published by Elsevier in Neuropharmacology
- Vol. 77, 422-427
Morphine modifies the cingulate–operculum network underlying painful rectal evoked potentials
- Open Access
- 1 January 2013
- Published by SAGE Publications in Molecular Pain
- Vol. 9 (1) , 19
Chronic Pain after Lower Abdominal Surgery: Do Catechol-O-Methyl Transferase/Opioid Receptor μ−1 Polymorphisms Contribute?
Background: Preoperative pain, type of operation and anesthesia, severity of acute postoperative pain, and psychosocial factors have been identified as risk factors for chronic postsurgical pain (CPP). Recently, it has been suggested that genetic factors also contribute to CPP. In this study, we aimed to determine whether the catechol-O-methyl transferase ( COMT) and opioid receptor μ−1 ( OPRM1) common functional polymorphisms rs4680 and rs1799971 were associated with the incidence, intensity, or duration of CPP in patients after lower abdominal surgery. Methods: One hundred and two patients with American Society of Anesthesiologists (ASA) physical status I/II underwent either abdominal radical prostatectomy (n=45) or hysterectomy (n = 57). The incidences of CPP in the pelvic and scar areas were evaluated in all patients three months after surgery. Results: Thirty-five (34.3%) patients experienced CPP after lower abdominal surgery. Within this group, six (17.1%) patients demonstrated symptoms of neuropathic pain. For COMT rs4680, 22 (21.6%) patients had Met158Met, 55 (53.9%) patients had Val158Met, and 25 (24.5%) patients had Val158Val. No association was found between CPP phenotypes (incidence, intensity, and duration) and different rs4680 genotypes. For OPRM1 rs1799971, only CPP patients carrying at least one copy of the G allele had higher pain intensity than A118A carriers (p=0.02). No associations with other phenotypes were found. No combined effect of COMT/OPRM1 polymorphisms on CPP phenotypes was observed. Conclusions: OPRM1 genotype influences CPP following lower abdominal surgery. COMT didn't affect CPP, suggesting its potential modality-specific effects on human pain.
- 1 January 2013
- Published by SAGE Publications in Molecular Pain
- Vol. 9 (1) , 19
Open AccessChronic Pain after Lower Abdominal Surgery: Do Catechol-O-Methyl Transferase/Opioid Receptor μ−1 Polymorphisms Contribute?
Background: Preoperative pain, type of operation and anesthesia, severity of acute postoperative pain, and psychosocial factors have been identified as risk factors for chronic postsurgical pain (CPP). Recently, it has been suggested that genetic factors also contribute to CPP. In this study, we aimed to determine whether the catechol-O-methyl transferase ( COMT) and opioid receptor μ−1 ( OPRM1) common functional polymorphisms rs4680 and rs1799971 were associated with the incidence, intensity, or duration of CPP in patients after lower abdominal surgery. Methods: One hundred and two patients with American Society of Anesthesiologists (ASA) physical status I/II underwent either abdominal radical prostatectomy (n=45) or hysterectomy (n = 57). The incidences of CPP in the pelvic and scar areas were evaluated in all patients three months after surgery. Results: Thirty-five (34.3%) patients experienced CPP after lower abdominal surgery. Within this group, six (17.1%) patients demonstrated symptoms of neuropathic pain. For COMT rs4680, 22 (21.6%) patients had Met158Met, 55 (53.9%) patients had Val158Met, and 25 (24.5%) patients had Val158Val. No association was found between CPP phenotypes (incidence, intensity, and duration) and different rs4680 genotypes. For OPRM1 rs1799971, only CPP patients carrying at least one copy of the G allele had higher pain intensity than A118A carriers (p=0.02). No associations with other phenotypes were found. No combined effect of COMT/OPRM1 polymorphisms on CPP phenotypes was observed. Conclusions: OPRM1 genotype influences CPP following lower abdominal surgery. COMT didn't affect CPP, suggesting its potential modality-specific effects on human pain.
- 20 December 2011
- Published by Elsevier in Experimental Neurology
- Vol. 233 (2) , 866-870
Neural cell adhesion molecule and its polysialic acid moiety exhibit opposing and linked effects on neuropathic hyperalgesia
- 20 December 2011
- Published by Elsevier in Experimental Neurology
- Vol. 233 (2) , 866-870
Neural cell adhesion molecule and its polysialic acid moiety exhibit opposing and linked effects on neuropathic hyperalgesia
- 2 August 2011
- Published by Elsevier in Brain Research
- Vol. 1404, 55-62
Removal of polysialylated neural cell adhesion molecule increases morphine analgesia and interferes with tolerance in mice
- 2 August 2011
- Published by Elsevier in Brain Research
- Vol. 1404, 55-62
Removal of polysialylated neural cell adhesion molecule increases morphine analgesia and interferes with tolerance in mice
- 1 February 2011
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 112 (2) , 448-453
Combined Catechol-O-Methyltransferase and μ-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects
Previous studies have generated controversial results regarding the influence of the genetic variations of μ-opioid receptors on morphine analgesia and opioid-related side effects in the postoperative period. Few studies have been conducted attempting to assess the combined effects of variation within ≥2 genes in relation to morphine response. In this study, we investigated whether combined catechol-O-methyltransferase and μ-opioid receptor polymorphisms contribute to the morphine response in postoperative analgesia. One hundred two surgical patients were enrolled in this prospective, observational study. All patients received general anesthesia and were screened for μ-opioid receptor polymorphism A118G (Asn40Asp) and catechol-O-methyltransferase G1947A (Val158Met) polymorphism using a blood sample of DNA. Patient-controlled analgesia was provided postoperatively and morphine consumption was observed. Any pain at rest or side effects were measured with rating scales. The heterozygous patients with μ-opioid receptor A118G and catechol-O-methyltransferase G1947A mutation consumed significantly less morphine in the postanesthetic recovery room and 48 hours after surgery compared with homozygous patients of the A118 variant. Nausea and sedation scores were also significantly lower during all observed postoperative periods for heterozygous patients and only 2 patients (18%) from this group received antinausea treatment. This study has demonstrated the importance of the gene-gene approach in understanding the morphine response in patients after lower abdominal surgery. More studies are needed to characterize the combined effects of multiple genes and demographic as well as clinical variables in predicting the correct morphine dosage and corresponding opioid-related side effects.
- 1 February 2011
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 112 (2) , 448-453
Combined Catechol-O-Methyltransferase and μ-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects
Previous studies have generated controversial results regarding the influence of the genetic variations of μ-opioid receptors on morphine analgesia and opioid-related side effects in the postoperative period. Few studies have been conducted attempting to assess the combined effects of variation within ≥2 genes in relation to morphine response. In this study, we investigated whether combined catechol-O-methyltransferase and μ-opioid receptor polymorphisms contribute to the morphine response in postoperative analgesia. One hundred two surgical patients were enrolled in this prospective, observational study. All patients received general anesthesia and were screened for μ-opioid receptor polymorphism A118G (Asn40Asp) and catechol-O-methyltransferase G1947A (Val158Met) polymorphism using a blood sample of DNA. Patient-controlled analgesia was provided postoperatively and morphine consumption was observed. Any pain at rest or side effects were measured with rating scales. The heterozygous patients with μ-opioid receptor A118G and catechol-O-methyltransferase G1947A mutation consumed significantly less morphine in the postanesthetic recovery room and 48 hours after surgery compared with homozygous patients of the A118 variant. Nausea and sedation scores were also significantly lower during all observed postoperative periods for heterozygous patients and only 2 patients (18%) from this group received antinausea treatment. This study has demonstrated the importance of the gene-gene approach in understanding the morphine response in patients after lower abdominal surgery. More studies are needed to characterize the combined effects of multiple genes and demographic as well as clinical variables in predicting the correct morphine dosage and corresponding opioid-related side effects.
- 1 July 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 638 (1-3) , 61-64
Topical methadone and meperidine analgesic synergy in the mouse
- 1 July 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 638 (1-3) , 61-64
Topical methadone and meperidine analgesic synergy in the mouse